← FDA Drug Approvals (Drugs@FDA)

BUMETANIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS CO · Approved 2017-10-18

Drug application

FDA Application #

ANDA209724

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUMETANIDE

Generic name

BUMETANIDE

Active ingredients

BUMETANIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AMNEAL PHARMS CO

Manufacturer

Amneal Pharmaceuticals NY LLC

First approval

2017-10-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown